Buscar
Mostrando ítems 1-10 de 1639
Development of a Recombinant Newcastle Disease Virus Vaccine and its Efficacy in a Broiler Farm
(2012-11-22)
Development of a Recombinant Newcastle Disease Virus Vaccine and its Efficacy in a Broiler Farm
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
(2023)
Respiratory syncytial virus (RSV) is responsible for a significant proportion of global morbidity and mortality affecting young children and older adults. In the aftermath of formalin-inactivated RSV vaccine development, ...
Confronting the barriers to develop novel vaccines against brucellosis
(Expert Reviews, 2011-09)
Brucellosis is an important zoonotic disease of nearly worldwide distribution. This pathogen causes abortion in domestic animals and undulant fever, arthritis, endocarditis and meningitis in humans. Currently, there is no ...
Perspectives of vaccination in Chagas disease revisited
(Instituto Oswaldo Cruz, Ministério da Saúde, 2009)
The perspectives for a Chagas Disease vaccine 30 years ago and today are compared. Antigens and adjuvants have improved, but logistic problems remain the same. Sterilizing vaccines have not been produced and animal models ...
Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
(Taylor & Francis, 2019-01)
Foot and mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals, which causes severe economic losses in the livestock industry. Currently available vaccines are based on inactivated FMD virus (FMDV). ...
Novel Recombinant BCG Vaccines: Do the Ordinary Platforms Matter?
(Omics International, 2015)
Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine
(Future Medicine Ltd, 2015)
Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit
(ELSEVIER SCI LTD, 2008)
Recombinant Bacillus subtilis strains, either spores or vegetative cells, may be employed as safe and low cost orally delivered live vaccine vehicles. In this study, we report the use of an orally delivered B. subtilis ...